A Case of Infant-Type Hemispheric Glioma with NTRK1 Fusion

Mekka R Garcia1, Lena Bell1, Claire Miller1

  • 1Department of Neurology, New York University, New York, NY, USA.

Child Neurology Open
|January 5, 2023
PubMed

Insights

A rare infant brain tumor case highlights neurotrophic tyrosine receptor kinase (NTRK) gene fusions in pediatric glioma. This severe case in a neonate with NTRK1 fusion complicated by seizures underscores treatment challenges.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Genetics

Background:

  • Childhood central nervous system tumors affect approximately 6 in 100,000 infants.
  • Recent research indicates that neurotrophic tyrosine receptor kinase (NTRK) gene fusions are present in 10% of non-brainstem high-grade gliomas in young children.
  • These NTRK fusions are suggested to have an oncogenic effect.

Observation:

  • This report details an extremely rare and severe case of a full-term neonate diagnosed with infant-type hemispheric glioma.
  • The infant presented at birth with significant symptoms including widely splayed sutures and a bulging fontanelle.
  • The tumor was found to harbor an NTRK1 gene fusion.

Findings:

  • The infant's condition was complicated by seizures that were resistant to medical management.
  • Due to the large size of the tumor mass, the patient was not considered a suitable candidate for surgery.
  • The family ultimately opted for comfort care for the infant.

Implications:

  • This case underscores the aggressive nature of infant-type hemispheric gliomas with NTRK fusions.
  • It highlights the diagnostic and therapeutic challenges associated with rare pediatric brain tumors.
  • Further research into NTRK fusion-driven pediatric gliomas is warranted to improve patient outcomes.